ERBB3 and breast cancer: It was discovered that HER3 was one of the presumptive targets of miR-205; miR-205 bound to the 3’UTR of HER3 and VEGF-A mRNA and then downregulated their levels, which resulted in the inhibition of breast cancer cell growth[160].